1 / 5

Cardiac Monitoring Market Size, Share and Trends

Due to the rising prevalence of CVDs, the cardiac monitoring market was valued at $7,965.7 million in 2021, which is expected to grow at a CAGR of 8.2% from 2021 to 2030, to reach $16,124.0 million by 2030. The continuous monitoring of heart health is essential due to lifestyle changes; as a result, medical technology businesses are introducing a variety of products.

psmarketresearch2017
Download Presentation

Cardiac Monitoring Market Size, Share and Trends

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiac Monitoring Market To Reach $16,124.0 Million by 2030 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  2. Due to the rising prevalence of CVDs, the cardiac monitoring market was valued at $7,965.7 million in 2021, which is expected to grow at a CAGR of 8.2% from 2021 to 2030, to reach $16,124.0 million by 2030. The continuous monitoring of heart health is essential due to lifestyle changes; as a result, medical technology businesses are introducing a variety of products. Biotricity Inc. launched Bioheart, a heart monitor that allows for rhythm tracking for 48 hours on a full battery, in November 2021. According to the WHO, CVDs are the largest cause of death worldwide, killing 17.9 million people each year. Excessive smoking of cigarettes, obesity, high cholesterol levels, poor nutrition, physical inactivity, diabetes, and alcohol consumption directly impair heart health. Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/cardiac- monitoring-market/report-sample Key Findings of Cardiac Monitoring Market Report • In 2021, the North American cardiac monitoring market accounted for $2,998.3 million in revenue, which will rise at a CAGR of 8.7% from 2021 to 2030. The increasing healthcare expenditure, growing prevalence of CVDs, advancing disposable income, and increasing healthcare knowledge drive the market in the region • Boston Scientific Corporation bought Preventice Solutions Inc. in January 2021 to offer portable ambulatory cardiac monitors and other devices that are essential to sound heart health. • Similarly, ZOLL Medical Corporation declared the purchase of Cardiac Science Corporation in August 2019 to increase AED production for cardiac monitoring and deliver related accessories and services. • The early identification of arrhythmias can help prevent serious heart events; as a result, the demand for cardiac monitoring devices is increasing since these devices can save patients in whom the risk of sudden cardiac arrest is high. • In 2021, hospitals produced approximately $3,070.3 million in cardiac monitoring market revenue, and it is expected to grow at a 7.8% CAGR in the forecast period. Every year, around 6.9% of the patients with ischemic heart disease or a history of myocardial infarction are hospitalized in the U.S. While, approximately 7.2% of the patients with heart illnesses end up in emergency rooms. 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  3. • data to healthcare experts via connected devices. In contrast, the percentages are roughly 12%, 17%, and 26% in Germany, Sweden, and the U.K., respectively. To attain a prominent foothold in the cardiac monitoring market, companies have launched new products and acquired other companies in recent years. Major companies in the market are Boston Scientific Corporation, GE Healthcare, Abbott Laboratories, BIOTRONIK, Nihon Kohden Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Hill-Rom Holdings, Medtronic plc, and Asahi Kasei Corporation. In 2021, the resting ECG category contributed roughly 38% of the sales revenue. This was due to the devices' ability to diagnose heart health more quickly and accurately than other monitoring technologies. These devices can also be utilized in conjunction with a variety of other telemetry monitoring equipment, diagnostic tests, and medical treatments. The research offers market size of the global cardiac monitoring market for the period 2017– 2030. Market Segmentation by Product Resting ECG Stress ECG MCT Holter Monitoring ICM Monitoring Cardiac Event Monitoring Cardiac Output Monitoring Market Segmentation by Mode Standard Ambulatory Market Segmentation by End User Hospitals Specialty Cardiac Centers & Clinics Diagnostic Centers Others Market Segmentation by Region North America Cardiac Monitoring Market In China and the U.A.E., 58% and 46% of the patients, respectively, send • • • • • • • • • • • • • • oBy product oBy mode 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  4. oBy end user oBy country – U.S. and Canada Europe Cardiac Monitoring Market • oBy product oBy mode oBy end user oBy country – U.K., Germany, France, Spain, Italy, and Rest of Europe Asia-Pacific (APAC) Cardiac Monitoring Market • oBy product oBy mode oBy end user oBy country – China, India, Japan, South Korea, Australia, and Rest of APAC Latin America (LATAM) Cardiac Monitoring Market • oBy product oBy mode oBy end user oBy country – Brazil, Mexico, Argentina, and Rest of LATAM Middle East and Africa (MEA) Cardiac Monitoring Market • oBy product oBy mode oBy end user oBy country – Turkey, Saudi Arabia, South Africa, and Rest of MEA 4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

  5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

More Related